News from MarketWatch Top Stories

All U.S. UK Canada Australia India Global Global (Crypto)

What is your interest today?

Bitcoin Crypto Btc Ceo Tariffs Stocks Investors Crypto Assets Cryptocurrency Shares Stock Stock Market Ethereum Price Markets Xrp Investment Blockchain Sec Etf Stablecoin Eth Trade Bse Index Ipo Earnings Solana Revenue China Coinbase Inflation Token Wall Street Nasdaq Interest Rates Sensex Trade War Usd Economy Gold Tesla Traders Nse Profit Treasury Digital Assets Federal Reserve Sp 500 Bse Sensex Corporate News Market Participants Multichain Foundation Close Brothers Trump Media Group Monthly Convention Sick Pay Venice Token Wood Group

Filter by:

Trial × Past year × MarketWatch Top Stories ×

MarketWatch Top Stories • May 30, 2025

Regeneron dashes Wall Street’s hopes as COPD treatment trial suffers a failure

The unsuccessful outcome of Regeneron’s advanced COPD therapy study led to a significant decline in its stock value, marking the company’s largest drop in over a decade on financia...

Read Full Article →